Skip to main content

NASDAQ: AGRX Agile Therapeutics Anticipates Increased Growth In Q3 of 2022

Contact Details

Matt Riley - Head of Investor Relations & Corporate Communications

mriley@agiletherapeutics.com

Company Website

https://agiletherapeutics.com/

Recent Quotes

View More
Symbol Price Change (%)
AMZN  208.56
+0.00 (0.00%)
AAPL  272.14
+0.00 (0.00%)
AMD  213.84
+0.00 (0.00%)
BAC  50.41
+0.00 (0.00%)
GOOG  310.92
+0.00 (0.00%)
META  639.30
+0.00 (0.00%)
MSFT  389.00
+0.00 (0.00%)
NVDA  192.85
+0.00 (0.00%)
ORCL  146.14
+0.00 (0.00%)
TSLA  409.38
+0.00 (0.00%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.